211 related articles for article (PubMed ID: 2201691)
21. Context surrounding processing sites is crucial in determining cleavage rate of a subset of processing sites in HIV-1 Gag and Gag-Pro-Pol polyprotein precursors by viral protease.
Lee SK; Potempa M; Kolli M; Özen A; Schiffer CA; Swanstrom R
J Biol Chem; 2012 Apr; 287(16):13279-90. PubMed ID: 22334652
[TBL] [Abstract][Full Text] [Related]
22. Crystal structure of human immunodeficiency virus (HIV) type 2 protease in complex with a reduced amide inhibitor and comparison with HIV-1 protease structures.
Tong L; Pav S; Pargellis C; Dô F; Lamarre D; Anderson PC
Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8387-91. PubMed ID: 8378311
[TBL] [Abstract][Full Text] [Related]
23. Regulation of autoproteolysis of the HIV-1 and HIV-2 proteases with engineered amino acid substitutions.
Rosé JR; Salto R; Craik CS
J Biol Chem; 1993 Jun; 268(16):11939-45. PubMed ID: 8505318
[TBL] [Abstract][Full Text] [Related]
24. Cell-mediated cleavage of Pseudomonas exotoxin between Arg279 and Gly280 generates the enzymatically active fragment which translocates to the cytosol.
Ogata M; Fryling CM; Pastan I; FitzGerald DJ
J Biol Chem; 1992 Dec; 267(35):25396-401. PubMed ID: 1460035
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the HIV-1 and HIV-2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag-Pol polyproteins.
Tözsér J; Bláha I; Copeland TD; Wondrak EM; Oroszlan S
FEBS Lett; 1991 Apr; 281(1-2):77-80. PubMed ID: 2015912
[TBL] [Abstract][Full Text] [Related]
26. Fluorescent oligopeptide substrates for kinetic characterization of the specificity of Astacus protease.
Stöcker W; Ng M; Auld DS
Biochemistry; 1990 Nov; 29(45):10418-25. PubMed ID: 2261483
[TBL] [Abstract][Full Text] [Related]
27. HIV protease (HIV PR) inhibitor structure-activity-selectivity, and active site molecular modeling of high affinity Leu [CH(OH)CH2]Val modified viral and nonviral substrate analogs.
Sawyer TK; Staples DJ; Liu L; Tomasselli AG; Hui JO; O'Connell K; Schostarez H; Hester JB; Moon J; Howe WJ
Int J Pept Protein Res; 1992; 40(3-4):274-81. PubMed ID: 1478785
[TBL] [Abstract][Full Text] [Related]
28. Mutational analysis of the substrate binding pockets of the Rous sarcoma virus and human immunodeficiency virus-1 proteases.
Cameron CE; Ridky TW; Shulenin S; Leis J; Weber IT; Copeland T; Wlodawer A; Burstein H; Bizub-Bender D; Skalka AM
J Biol Chem; 1994 Apr; 269(15):11170-7. PubMed ID: 8157644
[TBL] [Abstract][Full Text] [Related]
29. Mutating P2 and P1 residues at cleavage junctions in the HIV-1 pol polyprotein. Effects on hydrolysis by HIV-1 proteinase.
Jupp RA; Phylip LH; Mills JS; Le Grice SF; Kay J
FEBS Lett; 1991 Jun; 283(2):180-4. PubMed ID: 2044756
[TBL] [Abstract][Full Text] [Related]
30. Mechanism of inhibition of the retroviral protease by a Rous sarcoma virus peptide substrate representing the cleavage site between the gag p2 and p10 proteins.
Cameron CE; Grinde B; Jentoft J; Leis J; Weber IT; Copeland TD; Wlodawer A
J Biol Chem; 1992 Nov; 267(33):23735-41. PubMed ID: 1331099
[TBL] [Abstract][Full Text] [Related]
31. Insights into cleavage specificity from the crystal structure of foot-and-mouth disease virus 3C protease complexed with a peptide substrate.
Zunszain PA; Knox SR; Sweeney TR; Yang J; Roqué-Rosell N; Belsham GJ; Leatherbarrow RJ; Curry S
J Mol Biol; 2010 Jan; 395(2):375-89. PubMed ID: 19883658
[TBL] [Abstract][Full Text] [Related]
32. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.
Barrie KA; Perez EE; Lamers SL; Farmerie WG; Dunn BM; Sleasman JW; Goodenow MM
Virology; 1996 May; 219(2):407-16. PubMed ID: 8638406
[TBL] [Abstract][Full Text] [Related]
33. The primary structure of human liver manganese superoxide dismutase.
Barra D; Schinina ME; Simmaco M; Bannister JV; Bannister WH; Rotilio G; Bossa F
J Biol Chem; 1984 Oct; 259(20):12595-601. PubMed ID: 6386798
[TBL] [Abstract][Full Text] [Related]
34. Chemical synthesis of a biotinylated derivative of the simian immunodeficiency virus protease. Purification by avidin affinity chromatography and autocatalytic activation.
Tomasselli AG; Bannow CA; Deibel MR; Hui JO; Zurcher-Neely HA; Reardon IM; Smith CW; Heinrikson RL
J Biol Chem; 1992 May; 267(15):10232-7. PubMed ID: 1587812
[TBL] [Abstract][Full Text] [Related]
35. Kinetic and modeling studies of subsites S4-S3' of Moloney murine leukemia virus protease.
Menéndez-Arias L; Weber IT; Soss J; Harrison RW; Gotte D; Oroszlan S
J Biol Chem; 1994 Jun; 269(24):16795-801. PubMed ID: 8207003
[TBL] [Abstract][Full Text] [Related]
36. The differential processing of homodimers of reverse transcriptases from human immunodeficiency viruses type 1 and 2 is a consequence of the distinct specificities of the viral proteases.
Fan N; Rank KB; Leone JW; Heinrikson RL; Bannow CA; Smith CW; Evans DB; Poppe SM; Tarpley WG; Rothrock DJ
J Biol Chem; 1995 Jun; 270(22):13573-9. PubMed ID: 7539431
[TBL] [Abstract][Full Text] [Related]
37. Specificity of the wound-induced leucine aminopeptidase (LAP-A) of tomato activity on dipeptide and tripeptide substrates.
Gu YQ; Walling LL
Eur J Biochem; 2000 Feb; 267(4):1178-87. PubMed ID: 10672029
[TBL] [Abstract][Full Text] [Related]
38. Substrate specificities and inhibition of two hemorrhagic zinc proteases Ht-c and Ht-d from Crotalus atrox venom.
Fox JW; Campbell R; Beggerly L; Bjarnason JB
Eur J Biochem; 1986 Apr; 156(1):65-72. PubMed ID: 3514216
[TBL] [Abstract][Full Text] [Related]
39. Specificity of retroviral proteases: an analysis of viral and nonviral protein substrates.
Tomasselli AG; Heinrikson RL
Methods Enzymol; 1994; 241():279-301. PubMed ID: 7854182
[No Abstract] [Full Text] [Related]
40. Purification and biochemical characterization of recombinant simian immunodeficiency virus protease and comparison to human immunodeficiency virus type 1 protease.
Grant SK; Deckman IC; Minnich MD; Culp J; Franklin S; Dreyer GB; Tomaszek TA; Debouck C; Meek TD
Biochemistry; 1991 Aug; 30(34):8424-34. PubMed ID: 1883829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
